Global Anti-Allergy Drugs Market to Reach $58.5 Billion by 2030
The global market for Anti-Allergy Drugs estimated at US$36.3 Billion in the year 2023, is expected to reach US$58.5 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2023-2030. Pharmacies End-Use, one of the segments analyzed in the report, is expected to record a 8% CAGR and reach US$35.4 Billion by the end of the analysis period. Growth in the Hospitals End-Use segment is estimated at 6.2% CAGR for the next 7-year period.
The U.S. Market is Estimated at $9.5 Billion, While China is Forecast to Grow at 10.7% CAGR
The Anti-Allergy Drugs market in the U.S. is estimated at US$9.5 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$14.3 Billion by the year 2030 trailing a CAGR of 10.7% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.5% and 6.4% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$8.4 Billion by the year 2030.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook